4 Largecap Stocks With PB Between 3 and 6 to Watch for Future Multibagger Potential: Infosys, Sun Pharma, UltraTech Cement and Tech Mahindra

Stocks with PB between 3 and 6 to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Infosys, Sun Pharma, UltraTech Cement and Tech Mahindra meet that test, with market caps from Rs 1.60 lakh crore to Rs 4.47 lakh crore and Infosys offering the highest return on equity at 33.24%. Each of these companies has a price to book ratio between 3 and 6, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.

This list covers companies with a price to book ratio between 3 and 6, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, market capitalisation above Rs 1,00,000 crore, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening stocks with PB between 3 and 6 usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 26 October 2026 and are drawn from NSE and BSE data and company filings.

Click Here – Get Free Investment Predictions

What Are Stocks With PB Between 3 and 6 and Why Do They Attract Multibagger Interest?

Stocks with PB between 3 and 6 are shares that trade at 3 to 6 times book value, a range usually earned by businesses that make healthy returns on the capital invested in them. The four here cover IT services, pharmaceuticals and cement.

A price to book ratio in this range typically reflects a company that creates value well above its asset base. For stocks with PB between 3 and 6, both FY26 and the latest quarter showed growth. Whichever way you read stocks with PB between 3 and 6, the common thread is rising profit backed by complete financial data. For stocks with PB between 3 and 6, checking each result against the latest quarter matters more than any single ratio. The next sections explain what stands out in each of stocks with PB between 3 and 6, using FY26 and latest quarter data. Prices move daily, so recheck the figures for stocks with PB between 3 and 6 before you decide.

Stocks With PB Between 3 and 6 at a Glance: Price, Market Cap, PE and ROE

Prices are closing prices as of 26 October 2026. Infosys combines the lowest PE of the group, 14.73, with the highest return on equity, 33.24%.

Stock	CMP (Rs)	Market Cap (Rs Cr)	PE	Industry PE	ROE	Debt to Equity	52-Week Range (Rs)
Infosys	1,166	4,46,753	14.73	18.27	33.24%	0.10	980.40 to 1,728.00
Sun Pharmaceutical Industries	1,740	4,18,102	34.50	36.42	13.74%	0.06	1,583.70 to 2,046.90
UltraTech Cement	11,180	3,23,092	37.70	29.41	10.66%	0.31	10,325.00 to 13,110.00
Tech Mahindra	1,795	1,59,898	30.97	18.49	16.24%	0.07	1,304.10 to 1,854.00

Infosys: Return on Equity of 33.24%

Infosys is a large IT services and consulting company that has built an AI-first offering around its Topaz platform. It reported FY26 revenue of Rs 1,82,972 crore, up 9.83% year on year, and net profit of Rs 29,474 crore, up 10.18%. Net profit has compounded at 7.41% a year since FY22, while revenue has grown 10.23% a year. Operating margin was 25.36% in FY26. The debt-to-equity ratio is 0.10, which keeps interest costs low.

In the June 2026 quarter, revenue rose 13.56% to Rs 49,195 crore and net profit grew 12.29% to Rs 7,775 crore. Domestic institutions raised their holding from 39.60% in June 2025 to 42.96% in June 2026. The stock trades at a PE of 14.73 against an industry PE of 18.27, below the sector average, with a return on equity of 33.24%. The dividend yield is 4.35%.

Sun Pharma: 35.75% Profit CAGR Since FY22

Sun Pharmaceutical Industries is one of India's largest drugmakers and sells generic and specialty medicines in India and overseas. It reported FY26 revenue of Rs 61,673.94 crore, up 12.69% year on year, and net profit of Rs 11,564.52 crore, up 5.32%. Net profit has compounded at 35.75% a year since FY22, while revenue has grown 11.62% a year. Operating margin was 31.47% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.

The stock trades at a PE of 34.50 against an industry PE of 36.42, below the sector average, with a return on equity of 13.74%. In the June 2026 quarter, revenue rose 11.93% to Rs 16,023.50 crore and net profit grew 26.41% to Rs 2,910.80 crore. The share price has gained 110.81% over five years. Domestic institutions raised their holding from 20.23% in September 2025 to 22.27% in September 2026.

UltraTech Cement: Profit Compounding at 3.36% a Year

UltraTech Cement is the largest cement producer in India by capacity, with plants and grinding units across the country. It reported FY26 revenue of Rs 89,089.04 crore, up 16.15% year on year, and net profit of Rs 8,188.35 crore, up 35.58%. Revenue has compounded at 13.81% a year since FY22. Operating margin was 19.71% in FY26. The debt-to-equity ratio is 0.31.

In the June 2026 quarter, revenue rose 15.49% to Rs 24,778.47 crore and net profit grew 17.24% to Rs 2,603.72 crore. Domestic institutions raised their holding from 16.65% in September 2025 to 20.86% in September 2026. The stock trades at a PE of 37.70 against an industry PE of 29.41. The dividend yield is 2.19%.

Tech Mahindra: Debt-to-Equity of 0.07

Tech Mahindra, part of the Mahindra Group, provides IT and business services to telecom and other global clients. It reported FY26 revenue of Rs 56,847.30 crore, up 5.58% year on year, and net profit of Rs 4,805.50 crore, up 12.99%. Revenue has compounded at 5.57% a year since FY22. Operating margin was 15.47% in FY26. The debt-to-equity ratio is 0.07, which keeps interest costs low.

The stock trades at a PE of 30.97 against an industry PE of 18.49, with a return on equity of 16.24%. The dividend yield is 3.12%. In the September 2026 quarter, revenue rose 15.23% to Rs 16,172.80 crore and net profit grew 33.95% to Rs 1,609.70 crore. The share price is up 16.96% over the past year. Domestic institutions raised their holding from 32.13% in June 2025 to 36.92% in June 2026.

Stocks With PB Between 3 and 6: Financial Comparison on Growth and Margins

The table compares scale and growth across these stocks with PB between 3 and 6. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.

Stock	Revenue (Rs Cr)	Net Profit (Rs Cr)	Revenue Growth (YoY)	4-Year Revenue CAGR	Latest Quarter Revenue Growth	Operating Margin (Latest Quarter)
Infosys	1,82,972	29,474	9.83%	10.23%	13.56%	25.71%
Sun Pharma	61,673.94	11,564.52	12.69%	11.62%	11.93%	32.52%
UltraTech Cement	89,089.04	8,188.35	16.15%	13.81%	15.49%	20.83%
Tech Mahindra	56,847.30	4,805.50	5.58%	5.57%	15.23%	17.74%

Check the Univest Screener for live data on these stocks with PB between 3 and 6

Institutional Holding in Infosys, Sun Pharma, UltraTech Cement and Tech Mahindra

Institutional holding shows who is backing these stocks with PB between 3 and 6 alongside the promoter. The table uses the latest reported quarter for each. Infosys has the deepest institutional backing, with FII and DII together holding 70.05% as of June 2026. Domestic institutions increased their holding over the past year in Infosys (from 39.60% to 42.96%), Sun Pharma (from 20.23% to 22.27%), UltraTech Cement (from 16.65% to 20.86%) and Tech Mahindra (from 32.13% to 36.92%).

Stock	Promoter	FII	DII	Public	Quarter
Infosys	13.82%	27.09%	42.96%	16.13%	June 2026
Sun Pharma	52.68%	14.36%	22.27%	10.70%	September 2026
UltraTech Cement	58.48%	12.69%	20.86%	7.97%	September 2026
Tech Mahindra	34.97%	18.66%	36.92%	9.45%	June 2026

Risks to Weigh in Stocks With PB Between 3 and 6

Being careful with stocks with PB between 3 and 6 means looking at what can slow the story as well as what can speed it up. Four points matter most:

• Past growth may not repeat.
• Share prices can move sharply in either direction.
• Valuation: Tech Mahindra trades at a PE of 30.97 against an industry PE of 18.49, so earnings need to keep growing to support the price.
• Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.

How to Choose Between Stocks With PB Between 3 and 6

Picking from stocks with PB between 3 and 6 comes down to four checks, applied in order.

1. Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
2. Compare each PE with the industry PE (18.27 to 36.42) and ask whether the growth rate justifies any gap.
3. Track net profit growth, the operating margin and the return on equity in every quarterly result.
4. Stagger entries across quarters and review institutional holding every reporting season.

Download the Univest iOS App or Univest Android App to track Infosys, Sun Pharma, UltraTech Cement and Tech Mahindra live prices.

Conclusion

Among stocks with PB between 3 and 6, Infosys stands out for the highest return on equity at 33.24%, Sun Pharma for the fastest profit growth, 35.75% a year since FY22, UltraTech Cement for 16.15% revenue growth in FY26 and Tech Mahindra for the strongest latest-quarter profit growth at 33.95%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing stocks with PB between 3 and 6 should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Stocks With PB Between 3 and 6 to Watch

Which are the best stocks with PB between 3 and 6 to watch for multibagger potential?

Ans. Infosys, Sun Pharma, UltraTech Cement and Tech Mahindra are the 4 names this list highlights, with market caps of Rs 4,46,753 crore, Rs 4,18,102 crore, Rs 3,23,092 crore and Rs 1,59,898 crore respectively. Infosys is notable for the highest return on equity at 33.24%. Sun Pharma stands out for the fastest profit growth, 35.75% a year since FY22. UltraTech Cement offers 16.15% revenue growth in FY26. Tech Mahindra brings the strongest latest-quarter profit growth at 33.95%. These are watchlist names for stocks with PB between 3 and 6, not recommendations, so match each one to your own risk profile and time horizon.

Is Infosys a good stock for long-term investors?

Ans. Infosys has a return on equity of 33.24%, a PE of 14.73 against an industry PE of 18.27 and a market cap of Rs 4,46,753 crore. Net profit has compounded at 7.41% a year since FY22, and FY26 revenue rose 9.83% while June 2026 quarter net profit grew 12.29%. Long-term returns in stocks with PB between 3 and 6 depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.

Can Sun Pharma become a multibagger from here?

Ans. Sun Pharma has already gained 110.81% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in stocks with PB between 3 and 6 requires earnings to keep growing faster than the market for several years. Net profit has compounded at 35.75% a year since FY22, and FY26 revenue rose 12.69%. At a PE of 34.50 against an industry PE of 36.42, valuation should be checked against that growth before investing.

What is the market cap of Infosys, Sun Pharma, UltraTech Cement and Tech Mahindra?

Ans. As of 26 October 2026, Infosys has a market cap of Rs 4,46,753 crore, Sun Pharma has a market cap of Rs 4,18,102 crore, UltraTech Cement has a market cap of Rs 3,23,092 crore and Tech Mahindra has a market cap of Rs 1,59,898 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on stocks with PB between 3 and 6.

What are the risks of investing in stocks with PB between 3 and 6?

Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Tech Mahindra trades at a PE of 30.97 against an industry PE of 18.49, so earnings growth needs to hold up.

Why is Tech Mahindra trading at a PE of 30.97?

Ans. Tech Mahindra's PE of 30.97 compares with an industry PE of 18.49. The market is paying a premium for a return on equity of 16.24% and latest-quarter profit growth of 33.95%, which also means the stock is more sensitive if growth slows. Investors in stocks with PB between 3 and 6 who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.

How much do institutions hold in Infosys, Sun Pharma, UltraTech Cement and Tech Mahindra?

Ans. As of the latest reported quarter, FII and DII together hold 70.05% of Infosys (27.09% and 42.96%), 36.63% of Sun Pharma (14.36% and 22.27%), 33.55% of UltraTech Cement (12.69% and 20.86%) and 55.58% of Tech Mahindra (18.66% and 36.92%). Rising institutional holding is a useful signal in stocks with PB between 3 and 6, though it should be read with earnings trends rather than on its own.